相关实验视频
Updated: Jan 6, 2026

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.3K
静脉血栓溶解在血栓切除术的医院间转移前的晚期时间窗口中使用
Pierre Seners1,2,3, Nour Nehme4, Adrien Ter Schiphorst2,5
1Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France.
JAMA neurology
|December 1, 2025
概括
在由于大血管封闭 (AIS-LVO) 的急性缺血性中风中,在转移为内血管治疗 (EVT) 之前超过4.5小时内给予静脉血栓溶解 (IVT),改善了结局和再通道化. 这表明在晚期中风治疗窗口中的潜在益处.
科学领域:
- 神经学 神经学
- 干预神经病学 干预神经病学
- 脑卒中医学 脑卒中医学
背景情况:
- 静脉血栓溶解 (IVT) 在4.5小时以后的急性缺血性中风与大血管封闭 (AIS-LVO) 的疗效仍然不确定,特别是对于为内血管治疗 (EVT) 转移的患者.
- 之前的试验如TIMELESS专注于直接转移到综合性中风中心 (CSCs),可能限制了概括性.
研究的目的:
- 评估IVT在AIS-LVO患者4.5小时后开始的有效性和安全性,最初在初级中风中心 (PSC) 接受治疗,然后转移到CSC进行EVT.
- 为了确定早期IVT的管理是否会影响这个特定患者群体的再通道化率和功能结果.
主要方法:
- 一个多中心的回顾性队列研究,涉及20个法国PSC从2020年1月到2024年12月.
- 包括连续AIS-LVO患者入院>4.5小时从最后一个已知,转移到一个CSC为EVT,与或没有转移前IVT.
- 使用重叠权重的倾向评分 (PSOW) 来比较接受IVT和未接受IVT的患者之间的结果.
主要成果:
- 分析了584名患者;39.7%的患者在转移之前接受了IVT.
- 试管治疗的使用独立地与更好的3个月功能结果 (PSOW-OR,1.97) 和转移期间更高的再通道化几率 (PSOW-OR,8.69) 相关.
- 脑内出血的发病率在各组之间相似,这表明安全问题没有增加.
结论:
- 在AIS-LVO患者中,在为EVT进行医院间转移前超过4.5小时开始的IVT与改善的再通道化和功能结果有关.
- 这些发现支持进一步的临床试验,调查IVT在中风医院间转移之前的晚期时间窗口.
- 这项研究强调了早期IVT的潜在好处,即使EVT由于医院间转移而延迟.
相关概念视频
Venous Thrombosis III: Interprofessional Care
254
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
254
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
267
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
267
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
1.1K
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
1.1K
Pulmonary Embolism III: Nursing Management
311
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
311
Clot Retraction and Fibrinolysis
8.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.2K

